Seelos Therapeutics Inc
Change company Symbol lookup
Select an option...
SEEL Seelos Therapeutics Inc
RILY B Riley Financial Inc
BIIO Bionovate Technologies Corp
PGWFF PGG Wrightson Ltd
CRNX Crinetics Pharmaceuticals Inc
NDAQ Nasdaq Inc
PML PIMCO Municipal Income Fund II
BBLN Babylon Holdings Ltd
NEPT Neptune Wellness Solutions Inc

Health Care : Pharmaceuticals | Small Cap Growth
Company profile

Seelos Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development of products that address unmet needs in central nervous system (CNS) disorders and other rare disorders. The Company’s lead programs SLS-002 for the treatment of acute suicidal ideation and behavior (ASIB) in depressive disorder (MDD), and SLS-005 for the potential treatment of amyotrophic lateral sclerosis (ALS). SLS-005 for the potential treatment of Sanfilippo Syndromes, which is being explored. It is also developing several preclinical programs, including SLS-010, an oral histamine H3A receptor antagonist that shows promising activity in narcolepsy and related disorders, and SLS-012, an injectable therapy for post-operative pain management. The Company’s ongoing programs include SLS-004, SLS-006, SLS-007, and SLS-008.

Closing Price
Day's Change
0.07 (3.95%)
B/A Size
Day's High
Day's Low
(Below Average)

10-day average volume:
  • Prev Close
  • Today's Open
  • Day's Range
  • Avg Vol (10-day)
  • Last (time)
    4:00p ET 12/08/21
  • Last (size)
  • 52-Wk Range
    0.9301 - 6.60
  • (12/09/20 - 04/27/21)
  • 110.4%
  • Market Cap
  • Shares Outstanding
  • -0.60
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 2.8
  • 40.44
  • (% of float 11/15/21)

Latest News

December 06, 2021
8:01 am ET
PR Newswire
November 29, 2021
9:00 am ET
PR Newswire
November 24, 2021
9:31 am ET
PR Newswire
8:16 am ET
PR Newswire
7:16 am ET
PR Newswire
November 10, 2021
8:00 am ET
PR Newswire
November 08, 2021
8:00 am ET
PR Newswire
November 03, 2021
8:30 am ET
PR Newswire
November 02, 2021
8:00 am ET
PR Newswire
October 22, 2021
9:31 am ET
PR Newswire
October 01, 2021
8:00 am ET
PR Newswire
September 30, 2021
9:31 am ET
PR Newswire
September 22, 2021
10:40 am ET
PR Newswire
September 15, 2021
8:50 am ET
PR Newswire
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2021. All rights reserved.